Cathie Wood’s Top 15 Small-Cap Stock Picks
In this article, we discuss Cathie Wood’s top 15 small-cap stock picks.
Castle Biosciences Inc (CSTL)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 2,525,613 | $185,203 | -3% | 0.34% |
| 2. | Zevenbergen Capital Investments Nancy Zevenbergen | 542,926 | $39,813 | +96% | 0.7% |
| 3. | Driehaus Capital Richard Driehaus | 379,493 | $27,828 | +1% | 0.36% |
| 4. | Intrinsic Edge Capital Mark Coe | 169,965 | $12,464 | +325% | 0.73% |
| 5. | Citadel Investment Group Ken Griffin | 60,005 | $4,400 | -1% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.00 | 62,500 | Large Shareholder | 1,833,577 | 2019-07-29 | Filing | |
| $16.00 | 62,500 | Large Shareholder, Director | 1,833,577 | 2019-07-29 | Filing | |
| $16.00 | 134,700 | 134,700 | 2019-07-29 | Filing | ||
| $16.00 | 115,300 | 115,300 | 2019-07-29 | Filing | ||
| $16.00 | 62,500 | 1,496,855 | 2019-07-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.05 | 133 | Officer, Director | 140,032 | 2021-10-20 | Filing | |
| $65.04 | 700 | Officer, Director | 140,165 | 2021-10-20 | Filing | |
| $66.05 | 133 | Officer, Director | 152,634 | 2021-10-20 | Filing | |
| $65.04 | 700 | Officer, Director | 152,767 | 2021-10-20 | Filing | |
| $66.05 | 134 | Officer, Director | 129,794 | 2021-10-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 175,661 | $11,681 | 0.97% | |
| 2. | 32,998 | $2,194 | 0% | |
| 3. | 21,791 | $1,598 | 0.06% | |
| 4. | 7,960 | $529 | 1.55% | |
| 5. | 7,000 | $454 | 0% |
News See All
Were Hedge Funds Right About Dumping Castle Biosciences, Inc. (CSTL)?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Is CSTL A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think Castle Biosciences, Inc. (NASDAQ:CSTL) is a good investment right now.
Hedge Funds Are Getting Bullish On Castle Biosciences, Inc. (CSTL)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Are Betting On Castle Biosciences, Inc. (CSTL)
In this article we will check out the progression of hedge fund sentiment towards Castle Biosciences, Inc. (NASDAQ:CSTL) and determine whether it is a good investment right now.
Hedge Funds Have Never Been This Bullish On Castle Biosciences, Inc. (CSTL)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of June.
Hedge Fund and Insider Trading News: David Einhorn, Michael Hintze, Neil Woodford, Och-Ziff Capital Management, Universal Forest Products, Inc. (UFPI), Bristol-Myers Squibb Co (BMY), and More
David Einhorn has earned the attention of the investment community.
Billionaire Hedge Funds
